Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 233


European Academy of Cancer Sciences - position paper.

Adami HO, Berns A, Celis JE, de Vries E, Eggermont A, Harris A, Zur Hausen H, Pelicci PG, Ringborg U.

Mol Oncol. 2018 Nov;12(11):1829-1837. doi: 10.1002/1878-0261.12379. Epub 2018 Sep 21.


Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.

Calvo F, Apolone G, Baumann M, Caldas C, Celis JE, de Lorenzo F, Ernberg I, Ringborg U, Rowell J, Tabernero J, Voest E, Eggermont A.

Eur J Cancer. 2018 Nov;103:155-159. doi: 10.1016/j.ejca.2018.08.023. Epub 2018 Sep 18.


Thomas Tursz (1946-2018).

Ringborg U, Celis JE.

Mol Oncol. 2018 Sep;12(9):1413-1414. doi: 10.1002/1878-0261.12361. Epub 2018 Aug 2. No abstract available.


Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany.

Ortmann O, Helbig U, Torode J, Schreck S, Karjalainen S, Bettio M, Ringborg U, Klinkhammer-Schalke M, Bray F; participants of the ERTM.

J Cancer Res Clin Oncol. 2018 Jun;144(6):1097-1102. doi: 10.1007/s00432-018-2638-0. Epub 2018 Apr 9. Review.


European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence.

Ringborg U, Celis J, Eggermont A, Berns A.

Eur J Cancer. 2018 Apr;93:138-139. doi: 10.1016/j.ejca.2018.01.003. Epub 2018 Feb 14. No abstract available.


Current developments in cancer care: including the patients' perspective-3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany.

Ortmann O, Rösler W, Helbig U; participants of the ERTM.

J Cancer Res Clin Oncol. 2017 Apr;143(4):673-676. doi: 10.1007/s00432-016-2320-3. Epub 2016 Dec 17. Review.


Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.

Rajan A, Berns A, Ringborg U, Celis J, Ponder B, Caldas C, Livingston D, Bristow RG, Hecht TT, Tursz T, van Luenen H, Bono P, Helander T, Seamon K, Smyth JF, Louvard D, Eggermont A, van Harten WH.

Mol Oncol. 2016 May;10(5):645-51. doi: 10.1016/j.molonc.2015.12.007. Epub 2015 Dec 23. Review.


Optimizing sharing of hospital biobank samples.

Riegman PH, de Jong B, Daidone MG, Söderström T, Thompson J, Hall JA, Mendy M, Ten Hoeve J, Broeks A, Reed W, Morente MM, López-Guerrero JA, Collins VP, Rogan J, Ringborg U.

Sci Transl Med. 2015 Jul 22;7(297):297fs31. doi: 10.1126/scitranslmed.3009279.


Innovative clinical trials for development of personalized cancer medicine.

Mendelsohn J, Ringborg U, Schilsky R.

Mol Oncol. 2015 May;9(5):933-4. doi: 10.1016/j.molonc.2015.02.013. Epub 2015 Mar 5. No abstract available.


Translational cancer research: balancing prevention and treatment to combat cancer globally.

Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich C, Vineis P, McLaughlin J.

J Natl Cancer Inst. 2014 Dec 16;107(1):353. doi: 10.1093/jnci/dju353. Print 2015 Jan.


Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.

Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V; RARECARE Working Group.

Cancer Epidemiol. 2014 Dec;38(6):670-8. doi: 10.1016/j.canep.2014.09.009. Epub 2014 Oct 22.


Cancer Core Europe: a first step towards a virtual cancer institute in Europe?

Celis JE, Ringborg U.

Mol Oncol. 2014 Oct;8(7):1161-2. doi: 10.1016/j.molonc.2014.09.004. Epub 2014 Sep 18. No abstract available.


Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge.

Eggermont AM, Caldas C, Ringborg U, Medema R, Tabernero J, Wiestler O.

Eur J Cancer. 2014 Nov;50(16):2745-6. doi: 10.1016/j.ejca.2014.07.025. Epub 2014 Sep 25.


Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.

Saghatchian M, Thonon F, Boomsma F, Hummel H, Koot B, Harrison C, Rajan A, de Valeriola D, Otter R, Laranja Pontes J, Lombardo C, McGrath E, Ringborg U, Tursz T, van Harten W.

J Oncol Pract. 2014 Sep;10(5):e342-9. doi: 10.1200/JOP.2013.001331. Epub 2014 Aug 12.


Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.

Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG.

Cancer Epidemiol. 2013 Dec;37(6):850-6. doi: 10.1016/j.canep.2013.08.001. Epub 2013 Sep 16.


Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.

Tsimberidou AM, Ringborg U, Schilsky RL.

Am Soc Clin Oncol Educ Book. 2013:118-25. doi: 10.1200/EdBook_AM.2013.33.118. Review.


[The ethical review committees should become a single authority].

Munck J, Dahlquist G, Johansson G, Petersson B, Ringborg U.

Lakartidningen. 2013 Apr 10-16;110(15):773-4. Swedish. No abstract available.


Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.

van der Zwan JM, Trama A, Otter R, Larrañaga N, Tavilla A, Marcos-Gragera R, Dei Tos AP, Baudin E, Poston G, Links T; RARECARE WG.

Eur J Cancer. 2013 Jul;49(11):2565-78. doi: 10.1016/j.ejca.2013.02.029. Epub 2013 Mar 27.


Incidence, survival and prevalence of myeloid malignancies in Europe.

Visser O, Trama A, Maynadié M, Stiller C, Marcos-Gragera R, De Angelis R, Mallone S, Tereanu C, Allemani C, Ricardi U, Schouten HC; RARECARE Working Group.

Eur J Cancer. 2012 Nov;48(17):3257-66. doi: 10.1016/j.ejca.2012.05.024. Epub 2012 Jul 4.


Personalized cancer medicine - a strategy to counteract an increasing cancer challenge.

Mendelsohn J, Ringborg U, Schilsky RL.

Mol Oncol. 2012 Apr;6(2):109-10. doi: 10.1016/j.molonc.2012.03.002. Epub 2012 Mar 13. No abstract available.

Supplemental Content

Loading ...
Support Center